Omeza, a Sarasota-based advanced wound care company, recently announced a partnership with local physician Dr. John Yee as a sub-investigator for the company's Omeza Treatment Bundle for the treatment of chronic and complicated wounds. While product development, manufacturing, and corporate headquarters have been located in Sarasota since the company’s formation in 2016, most Omeza clinical trial sites to date have been located elsewhere around the country.
With Yee joining as a local sub-investigator, Omeza will be able to offer eligible patients in the area access to participate in this expanded indications trial, which will allow investigators to preliminarily evaluate the potential effectiveness of the Omeza Treatment Bundle. The study, called will take place over a period of 12 weeks per patient. Patient indications include partial and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (donor sites/grafts, post-Mohs surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, skin tears) and draining wounds. For more information, click here.